Document Detail


Acute occlusion of popliteal and/or tibial arteries: the value of percutaneous treatment.
MedLine Citation:
PMID:  10944099     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: to describe early and mid-term results with a percutaneous therapeutic protocol including thromboaspiration, thrombolysis, and correction of the underlying lesion by PTA. METHODS: thirty-three consecutive selected patients with recent (<1 month) reversible acute ischaemia associated with popliteal and/or tibial occlusion were studied. The primary endpoints were technical success (defined as residual mural thrombus less than 20% of the lumen and the presence of at least one tibial artery on angiogram), patient survival and limb salvage at 1 and 12 months. Secondary endpoints included complications, primary, assisted primary and secondary patency determined by duplex scan at 1, 6 and 12 months. RESULTS: technical success was achieved in 27 patients (82%). Twenty patients were treated by thrombo- aspiration+/-thrombolysis only, and seven required additional PTA (26%). In six patients (18%), percutaneous techniques failed, and embolectomy was performed in two, bypass in one and major amputations in three (9%). For the entire series, the survival rate was 100% at 1 month and 94% at 1 year. The limb salvage rate was 91% at 1 month and 1 year. The cumulative primary patency, assisted primary patency and secondary patency rates were 81%, 81% and 86% respectively at 1 month and 66%, 72% and 77%, respectively, at 12 months. Early complications occurred in 10 patients (30%): five groin haematomas (15%), four compartment syndromes (12%) and one haemoglobinuria (3%). CONCLUSION: percutaneous techniques offer excellent early and mid-term results in selected patients presenting with acute ischaemia with popliteal and/or tibial arteries occlusion.
Authors:
P Desgranges; K Kobeiter; A d'Audiffret; D Mellière; D Mathieu; J P Becquemin
Related Documents :
3207329 - Does oedema following lower limb revascularisation cause compartment syndromes?
14581779 - Limb salvage in bone sarcomas in patients younger than age 10: a 20-year experience.
11497369 - Limb lengthening in short stature patients.
20567929 - The obstructed pancreatico-biliary drainage limb: presentation, management, and outcomes.
14646649 - Long-term results of replantation for complete ring avulsion amputations.
3562109 - Murk jansen's metaphyseal chondrodysplasia with long-term followup.
20640139 - Our preliminary experience with lma c-trach.
22476409 - Transnasal endoscopic resection of a nasopharyngeal pleomorphic adenoma: a rare case re...
23406289 - Laparoscopic ventral rectopexy for rectal prolapse and symptomatic rectocele: an analys...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery     Volume:  20     ISSN:  1078-5884     ISO Abbreviation:  Eur J Vasc Endovasc Surg     Publication Date:  2000 Aug 
Date Detail:
Created Date:  2000-09-21     Completed Date:  2000-09-21     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9512728     Medline TA:  Eur J Vasc Endovasc Surg     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  138-45     Citation Subset:  IM    
Copyright Information:
Copyright 2000 Harcourt Publishers Ltd.
Affiliation:
Service de Chirurgie Vasculaire, Hôpital Henri Mondor, 51 avenue du Mal de Lattre de Tassigny, Créteil, 94000, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Aged
Aged, 80 and over
Angioplasty, Balloon / adverse effects,  methods*
Arterial Occlusive Diseases / classification,  mortality,  radiography,  therapy*
Combined Modality Therapy
Embolectomy / adverse effects,  methods*
Female
Follow-Up Studies
Humans
Male
Middle Aged
Plasminogen Activators / therapeutic use
Popliteal Artery*
Suction / adverse effects,  methods*
Survival Analysis
Thrombectomy / adverse effects,  methods*
Thrombolytic Therapy / adverse effects,  methods*
Tibial Arteries*
Treatment Outcome
Urokinase-Type Plasminogen Activator / therapeutic use
Vascular Patency
Chemical
Reg. No./Substance:
EC 3.4.21.-/Plasminogen Activators; EC 3.4.21.73/Urokinase-Type Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Suction blister grafting for stable vitiligo using pulsed erbium:YAG laser ablation for recipient si...
Next Document:  Risk factors for occlusion of infrainguinal bypass grafts.